10 Opportunities Most Manufacturers Haven’t Yet Leveraged
Cannabis manufacturing will soon carry the compliance burden of pharma without the operational infrastructure pharma built over decades. The gap isn’t effort or capital — it’s that few operators have had the knowledge or focus to assess where their processes actually stand. Below are ten disciplines routinely deployed in FDA-regulated manufacturing that remain largely untouched in cannabis operations today.
|
1 |
Process Capability Analysis. Most facilities track pass/fail on potency and dosage specs but never calculate Cpk — leaving them blind to how close they run to the edge of an out-of-spec batch. |
| 2 | Standardized Work. Batch-to-batch and shift-to-shift variability is usually a documentation gap, not a skill gap: operators fill it in with tribal knowledge that leaves when they do. |
| 3 | Value Stream Mapping. Extraction and packaging lines routinely carry 30–40% non-value- added time in waiting, rework, and hand-offs that no one has ever mapped end to end. |
|
4 |
Error-Proofing (Poka-Yoke). Mislabeling and cross-contamination risk is typically managed by training and inspection — the two least reliable controls in the quality hierarchy — instead of physical or system-level error-proofing. |
| 5 | Statistical Process Control. Real-time SPC on potency, moisture, and fill weight catches drift before it becomes a failed COA; most operators only find out after the lab test comes back. |
|
6 |
Total Productive Maintenance. Unplanned downtime on extraction and packaging equipment is treated as a maintenance problem, when it is usually an operational excellence problem with a measurable root cause. |
|
7 |
Change Readiness Assessment. New SOPs and equipment fail to stick not because the process was wrong, but because no one assessed whether the organization — leadership and floor staff — was ready to adopt it. |
|
8 |
Data-Driven Yield Optimization. Yield loss is frequently accepted as a cost of doing business rather than root-caused, even though the data to diagnose it already exists in most seed-to-sale systems. |
|
9 |
Structured Root Cause Problem-Solving. Deviations and OOS results get closed out with a corrective action that treats the symptom, because the organization has no structured method for finding the actual cause. |
|
10 |
Compliance-Ready Documentation Systems. Most quality systems are built to pass the next inspection, not to survive a scaling audit trail — a distinction that only becomes expensive after the fact. |
Dr. Ken Feldman is an LSS Master Black with over four decades helping organizations deploy operational excellence inside a wide variety of industries including pharmaceutical manufacturers (Merck, Eli Lilly, Roche, Genentech, and Fresenius Kabi). Optec Consulting brings that same rigor to cannabis manufacturing operators.
